Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    Open Studies | "Meningioma"
Show Display Options
Rank Status Study
21 Recruiting Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Conditions: Childhood Choroid Plexus Tumor;   Childhood Ependymoblastoma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: palbociclib isethionate;   Other: pharmacological study;   Other: laboratory biomarker analysis
22 Recruiting Multisession Radiosurgery for Optic Nerve Sheath Meningiomas
Condition: Optic Nerve Sheath Tumors, Benign
Intervention: Radiation: Multisession Radiosurgery
23 Unknown  Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer
Interventions: Drug: verteporfin;   Procedure: conventional surgery
24 Recruiting Collecting and Storing Tissue From Young Patients With Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis
25 Unknown  Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
26 Recruiting Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy
Condition: Radiation of Neurocranial Region
Interventions: Radiation: Radiation according to indication with hippocampal sparing;   Radiation: Radiation according to indication without hippocampal protection
27 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
28 Unknown  Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
29 Recruiting Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Condition: Brain Tumors
Intervention: Procedure: fMRI Evaluation
30 Not yet recruiting Safety Study of Afatinib for Brain Cancer
Condition: Brain Cancer
Intervention: Drug: Afatinib
31 Unknown  Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Metastatic Cancer
Interventions: Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Procedure: magnetic resonance imaging
32 Recruiting Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
Condition: Brain Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years